|
Market Closed -
Euronext Paris
11:55:00 2026-08-12 am EDT
|
5-day change | 1st Jan Change | ||
| 0.7310 EUR | -5.19% |
|
+4.13% | -52.41% |
| Aug. 10 | AB Science Wraps Up EUR14 Million Private Placements | MT |
| Aug. 10 | AB Science raises €14.2m |  |
| Market Cap | 58.49M 67.51M 54.8M 49.99M 93.97M 6.44B 95.42M 645M 252M 3.22B 253M 248M 10.75B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 58.49M 67.51M 54.8M 49.99M 93.97M 6.44B 95.42M 645M 252M 3.22B 253M 248M 10.75B | EV / Sales 2026 * |
48.7x | EV / Sales 2027 * | 45x |
| Free-Float |
63.24% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: AB Science
| 1 day | -5.19% | ||
| 1 week | +4.13% | ||
| Current month | +35.12% | ||
| 1 month | -0.27% | ||
| 3 months | -24.17% | ||
| 6 months | -45.04% | ||
| Current year | -52.41% |
| 1 week | 0.73 |  | 1 |
| 1 month | 0.5 | | 1 |
| Current year | 0.5 | | 1.61 |
| 1 year | 0.5 | | 1.68 |
| 3 years | 0.5 | | 4.46 |
| 5 years | 0.5 | | 14.65 |
| 10 years | 0.5 | | 21.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2026-07-06 | |
Laurent Guy
DFI | Director of Finance/CFO | - | 2009-11-19 |
| Chief Tech/Sci/R&D Officer | - | 2018-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Alain Moussy
CHM | Chairman | - | 2001-07-10 |
Patrick Moussy
BRD | Director/Board Member | - | 2011-09-19 |
| Director/Board Member | 64 | 2021-06-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/9/21 | Sell | Founder | 14,525 | 0.0315% | ||
| 2/2/21 | Sell | Founder | 76,104 | 0.1652% | ||
| 2/2/21 | Sell | Founder | 12,904 | 0.0280% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.19% | +4.13% | -45.85% | -77.12% | 71.19M | |
| +1.92% | +3.58% | +65.53% | +23.72% | 322B | |
| 0.00% | -3.45% | +26.07% | -14.27% | 70.24B | |
| -0.81% | +21.77% | +58.95% | +132.66% | 11.65B | |
| +0.04% | +3.08% | -1.50% | -2.96% | 8.42B | |
| -2.54% | +7.56% | -10.73% | -6.86% | 5.02B | |
| -2.92% | +10.65% | -25.14% | +15.26% | 4.52B | |
| -0.76% | +13.44% | +2.89% | +48.08% | 4.25B | |
| +2.11% | +2.05% | +16.08% | +50.11% | 2.72B | |
| -2.00% | -0.14% | -1.79% | -1.14% | 2.28B | |
| Average | -1.02% | +6.21% | +8.45% | +16.75% | 43.09B | |
| Weighted average by Cap. | +1.35% | +3.04% | +54.47% | +19.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.2M 1.39M 1.12M 1.03M 1.93M 132M 1.96M 13.22M 5.17M 66.15M 5.2M 5.09M 221M | 1.3M 1.5M 1.22M 1.11M 2.09M 143M 2.12M 14.33M 5.6M 71.66M 5.63M 5.51M 239M |
| Net income | - | - |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
Sep. 30
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-12 | €0.7310 | -5.19% | 589,361 |
| 26-08-11 | €0.7710 | +3.35% | 1,504,496 |
| 26-08-10 | €0.7460 | -25.40% | 2,914,127 |
| 26-08-07 | €1.000 | +24.07% | 1,075,191 |
| 26-08-06 | €0.8060 | +14.81% | 2,311,272 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AB Stock
Select your edition
All financial news and data tailored to specific country editions
